Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry—Plasma peptidomes from nasopharyngeal cancer patients for example-Reference-Cited by-同舟云学术

Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry—Plasma peptidomes from nasopharyngeal cancer patients for example

Published:2006-12 Issue:12 Volume:39 Page:1144-1151
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Chang Joseph Tung-Chieh,Chen Li-Chiu,Wei Shang-Yi,Chen Yin-Ju,Wang Hung-Ming,Liao Chun-Ta,Chen I-How,Cheng Ann-Joy

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference34 articles.

1. Proteomics: new perspectives, new biomedical opportunities;Banks;Lancet,2000

2. Design of proteome-based studies in combination with serology for the identification of biomarkers and novel targets;Seliger;Proteomics,2002

3. A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma;Steel;Proteomics,2003

4. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer;Li;Clin. Chem.,2002

5. The ProteinChip biomarker system from ciphergen biosystems: a novel proteomics platform for rapid biomarker discovery and validation;Chapman;Biochem. Soc. Trans.,2002

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Proteomics: New Horizons and Insights into Therapeutic Applications;Current Proteomics;2021-08-10

2. The Activation of Prothrombin Seems to Play an Earlier Role than the Complement System in the Progression of Colorectal Cancer: A Mass Spectrometry Evaluation;Diagnostics;2020-12-11

3. Modelling biological age based on plasma peptides in Han Chinese adults;Aging;2020-06-05

4. Identification of candidate biomarker mass (m/z) ranges in serous ovarian adenocarcinoma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling;Biomarkers;2015-07-04

5. Fascin is a circulating tumor marker for head and neck cancer as determined by a proteomic analysis of interstitial fluid from the tumor microenvironment;Clinical Chemistry and Laboratory Medicine (CCLM);2015-01-01